Table 5.

Recent long-term allogeneic bone marrow transplantation (BMT) results.18,;26,;28 30 

NSurvivalAgeSource
Abbreviations: TAI, thoracoabdominal irradiation; Cy, cyclophosphamide; ATG, antithymocyte globulin; GVHD, graft-versus-host disease; CsA, cyclosporine; MTX, methotrexate 
133 59% at 16 y for TAI/Cy
 95% at 4.4 y for ATG/Cy 55% < 20 y France 
211 89% at 20 y without GVHD
 69% at 20 y with GVHD 18 y FHCRC 
915 Actuarial survival 77% for patients
 68% for patients 17–40 y
 54% for patients > 40 y ≤ 16 y EBMT 
61 At 6 y 79% 14–40 y Korea 
71 94% at 8 y with CsA/MTX
 78% at 7 y with CsA 20 y GITMO 
1699 5 y survival: 75% for patients ≤ 20 y
 68% for patients 20–40 y
 35% for patients > 40 y  IBMTR 
NSurvivalAgeSource
Abbreviations: TAI, thoracoabdominal irradiation; Cy, cyclophosphamide; ATG, antithymocyte globulin; GVHD, graft-versus-host disease; CsA, cyclosporine; MTX, methotrexate 
133 59% at 16 y for TAI/Cy
 95% at 4.4 y for ATG/Cy 55% < 20 y France 
211 89% at 20 y without GVHD
 69% at 20 y with GVHD 18 y FHCRC 
915 Actuarial survival 77% for patients
 68% for patients 17–40 y
 54% for patients > 40 y ≤ 16 y EBMT 
61 At 6 y 79% 14–40 y Korea 
71 94% at 8 y with CsA/MTX
 78% at 7 y with CsA 20 y GITMO 
1699 5 y survival: 75% for patients ≤ 20 y
 68% for patients 20–40 y
 35% for patients > 40 y  IBMTR 

or Create an Account

Close Modal
Close Modal